| Old Articles: <Older 29111-29120 Newer> |
|---|
 |
The Motley Fool
March 14, 2008
Rick Aristotle Munarriz |
Diary of a Stock Market Loser A Motley Fool investor allows readers to follow along weekly as he attempts to improve his results.   |
The Motley Fool
March 14, 2008
Toby Shute |
These Boats Have a Moat TBS International is a shipper that turns awkward cargoes into cash flows. |
The Motley Fool
March 13, 2008
Rich Duprey |
Boston Beer's Frothy Quarter Rising sales of the Sam Adams and Twisted Tea brands at Boston Beer are able to stave off rising costs -- for now. |
The Motley Fool
March 13, 2008
Brian Orelli |
Humana's Hurting The health insurer's miscalculation causes it to drop guidance. |
The Motley Fool
March 13, 2008
Timothy M. Otte |
Jo-Ann Stores on the Mend The fabric and crafts retailer seems on the way to recovery, turning in their fourth straight quarter of positive comps. |
The Motley Fool
March 13, 2008
Brian Orelli |
Progenics Down but Not Out Progenics Pharmaceuticals' drug to help patients after abdominal surgery fails in its phase 3 trial. Investors, take note. |
The Motley Fool
March 13, 2008
Anders Bylund |
New Stocks on the Block These IPOs are scheduled for next week: CardioNet... Pogo Jet... Visa... |
The Motley Fool
March 13, 2008
Alyce Lomax |
Hot Topic's Slow Burn The Goth-inspired retailer reported an increase in fourth-quarter profit, but the fact that its sales are still flagging doesn't give investors much reason to celebrate. |
The Motley Fool
March 13, 2008
Rick Aristotle Munarriz |
5 More Stocks on Microsoft's Buy List Here are five companies that Microsoft should consider purchasing for better, and cheaper, growth prospects online. |
The Motley Fool
March 13, 2008
Stephen Albainy-Jenei |
Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex. |
| <Older 29111-29120 Newer> Return to current articles. |
